Variant report

Variant	nsv969373
Chromosome Location	chr6:29717694-29719688
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:15)
CpG islands
(count:734)
Chromatin interactive
region (count:5)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:15 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr6:29717506-29717801	K562	blood:	n/a	n/a
2	CTCF	chr6:29717820-29717970	WERI-Rb-1	eye:	n/a	n/a
3	ELK1	chr6:29717827-29717873	K562	blood:	n/a	n/a
4	EP300	chr6:29719634-29719721	K562	blood:	n/a	n/a
5	HCFC1	chr6:29716302-29717779	K562	blood:	n/a	n/a
6	JUN	chr6:29717484-29717811	HepG2	liver:	n/a	chr6:29717659-29717668 chr6:29717658-29717671
7	JUN	chr6:29717515-29717734	K562	blood:	n/a	chr6:29717659-29717668 chr6:29717658-29717671
8	JUND	chr6:29717270-29717830	K562	blood:	n/a	chr6:29717659-29717668
9	JUND	chr6:29717492-29717822	HepG2	liver:	n/a	chr6:29717659-29717668
10	POLR2A	chr6:29716473-29717834	PFSK-1	brain:	n/a	n/a
11	POLR2A	chr6:29717896-29717946	MCF10A-Er-Src	breast:	n/a	n/a
12	POLR2A	chr6:29718892-29718900	GM12878	blood:	n/a	n/a
13	POLR2A	chr6:29718284-29718464	MCF10A-Er-Src	breast:	n/a	n/a
14	RELA	chr6:29716550-29717846	GM15510	blood:	n/a	n/a
15	ZC3H11A	chr6:29719372-29719641	K562	blood:	n/a	n/a

(count:734 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:29719096-29719146	HEEpiC	esophagus:	n/a
2	chr6:29719180-29719230	NHDF-neo	bronchial:	n/a
3	chr6:29719096-29719146	HEEpiC	esophagus:	n/a
4	chr6:29719180-29719230	NHDF-neo	bronchial:	n/a
5	chr6:29718093-29718143	Hepatocyte	liver:	n/a
6	chr6:29719081-29719131	AG10803	skin:	n/a
7	chr6:29717917-29717967	NT2-D1	testis:	n/a
8	chr6:29719569-29719619	HPAEpiC	pulmonary alveolar:	n/a
9	chr6:29717917-29717967	NB4	blood:	n/a
10	chr6:29719096-29719146	NT2-D1	testis:	n/a
11	chr6:29718049-29718099	HAEpiC	amniotic membrane:	n/a
12	chr6:29719411-29719461	HEK293	kidney:	embryo
13	chr6:29717917-29717967	GM06990	blood:	n/a
14	chr6:29718049-29718099	NB4	blood:	n/a
15	chr6:29719096-29719146	NHDF-neo	bronchial:	n/a
16	chr6:29719081-29719131	RPTEC	kidney:	n/a
17	chr6:29718869-29718919	GM06990	blood:	n/a
18	chr6:29719569-29719619	AG04450	lung:	fetal
19	chr6:29717656-29717706	ProgFib	skin:	n/a
20	chr6:29718119-29718169	IMR90	lung:	fetal
21	chr6:29719096-29719146	HRE	kidney:	n/a
22	chr6:29718119-29718169	H1-hESC	embryonic stem cell:	embryo
23	chr6:29719180-29719230	SK-N-SH	brain:	n/a
24	chr6:29718093-29718143	ProgFib	skin:	n/a
25	chr6:29719180-29719230	Jurkat	blood:	n/a
26	chr6:29719180-29719230	GM06990	blood:	n/a
27	chr6:29719569-29719619	HMEC	breast:	n/a
28	chr6:29719096-29719146	AG09319	gingival:	n/a
29	chr6:29717651-29717701	SKMC	muscle:	n/a
30	chr6:29717656-29717706	MCF10A-Er-Src	breast:	n/a
31	chr6:29717651-29717701	HRE	kidney:	n/a
32	chr6:29718093-29718143	GM12878	blood:	n/a
33	chr6:29718119-29718169	GM12891	blood:	n/a
34	chr6:29718093-29718143	Caco-2	colon:	n/a
35	chr6:29719180-29719230	HPAEpiC	pulmonary alveolar:	n/a
36	chr6:29717917-29717967	HEEpiC	esophagus:	n/a
37	chr6:29717917-29717967	HCF	heart:	n/a
38	chr6:29719411-29719461	HCT-116	colon:	n/a
39	chr6:29718049-29718099	ProgFib	skin:	n/a
40	chr6:29719180-29719230	HCT-116	colon:	n/a
41	chr6:29719081-29719131	SKMC	muscle:	n/a
42	chr6:29719411-29719461	HUVEC	blood vessel:	n/a
43	chr6:29717651-29717701	Hela-S3	cervix:	n/a
44	chr6:29718119-29718169	CMK	blood:	n/a
45	chr6:29718119-29718169	U87	brain:	n/a
46	chr6:29719081-29719131	H1-hESC	embryonic stem cell:	embryo
47	chr6:29719081-29719131	CMK	blood:	n/a
48	chr6:29717651-29717701	MCF10A-Er-Src	breast:	n/a
49	chr6:29719096-29719146	SK-N-MC	brain:	n/a
50	chr6:29718093-29718143	AG09319	gingival:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:29595494..29598412-chr6:29717928..29720060,2	K562	blood:
2	chr6:29716316..29718223-chr6:29719581..29721724,2	MCF-7	breast:
3	chr6:29718134..29720156-chr6:31462731..31465532,2	MCF-7	breast:
4	chr6:29719431..29722230-chr6:29728984..29731849,2	MCF-7	breast:
5	chr6:29716316..29718223-chr6:29719581..29721724,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HLA-F-2	chr6:29718330-29718868	NONHSAT108546

No data

Variant related genes	Relation type
IFITM4P	TF binding region
MICE	TF binding region
ENSG00000199290	TF binding region
HLA-F-AS1	TF binding region
IFITM4P	CpG island
MICE	CpG island
ENSG00000199290	CpG island
HLA-F-AS1	CpG island
ENSG00000204681	chromatin interactions
ENSG00000273340	chromatin interactions
ENSG00000214922	chromatin interactions
ENSG00000201680	chromatin interactions
ENSG00000199290	chromatin interactions
ENSG00000272236	chromatin interactions
ENSG00000270896	chromatin interactions

Extended variants
information (count: 90 )
Associated
traits (count: 105 )

Variant overlapped rSNPs/rCNVs (count:90 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs148260382	chr6:29717718-29717719	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs192530037	chr6:29717744-29717745	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs139200024	chr6:29717766-29717767	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs1737083	chr6:29717811-29717812	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs9258244	chr6:29717817-29717818	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs1633080	chr6:29717826-29717827	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs541547786	chr6:29717866-29717867	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs1737082	chr6:29717902-29717903	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs577888621	chr6:29717930-29717931	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs733841	chr6:29717980-29717981	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs562986423	chr6:29718004-29718005	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs528866545	chr6:29718025-29718026	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs733839	chr6:29718094-29718095	Weak transcription Enhancers Active TSS	CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs2517934	chr6:29718165-29718166	Weak transcription Enhancers Active TSS	CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs547706681	chr6:29718194-29718195	Weak transcription Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs571100402	chr6:29718219-29718220	Weak transcription Active TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs4713242	chr6:29718220-29718221	Weak transcription Active TSS Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs2517933	chr6:29718224-29718225	Weak transcription Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs115247407	chr6:29718225-29718226	Weak transcription Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs535874089	chr6:29718230-29718231	Weak transcription Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs555867047	chr6:29718267-29718268	Weak transcription Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs112473393	chr6:29718281-29718282	Weak transcription Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs733840	chr6:29718282-29718283	Weak transcription Active TSS Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs557715051	chr6:29718292-29718293	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs577861213	chr6:29718328-29718329	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs537441657	chr6:29718330-29718331	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
27	rs553205318	chr6:29718331-29718332	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
28	rs556292224	chr6:29718340-29718341	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
29	rs909729	chr6:29718355-29718356	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs1610733	chr6:29718383-29718384	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs1610734	chr6:29718401-29718402	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs376081908	chr6:29718416-29718417	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
33	rs184808838	chr6:29718434-29718435	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
34	rs141900996	chr6:29718437-29718438	Weak transcription Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	4 gene(s)	Overlapped CNVs	n/a
35	rs1610735	chr6:29718519-29718520	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs547965288	chr6:29718541-29718542	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
37	rs1610736	chr6:29718544-29718545	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs573015865	chr6:29718562-29718563	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
39	rs533576702	chr6:29718576-29718577	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
40	rs3823318	chr6:29718578-29718579	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs570381539	chr6:29718630-29718631	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
42	rs62391840	chr6:29718690-29718691	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs529292366	chr6:29718712-29718713	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs386353036	chr6:29718751-29718752	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
45	rs199570734	chr6:29718752-29718753	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
46	rs9280691	chr6:29718753-29718754	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
47	rs1610621	chr6:29718790-29718791	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs566162397	chr6:29718795-29718796	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
49	rs376306027	chr6:29718802-29718803	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
50	rs534847397	chr6:29718809-29718810	Weak transcription Active TSS Enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:105)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Breast cancer	21509527	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:199 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:29715400-29717800	Flanking Active TSS	Stomach Smooth Muscle	stomach
2	chr6:29715600-29718000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
3	chr6:29716000-29717800	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
4	chr6:29716400-29717800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr6:29716800-29717800	Enhancers	Placenta Amnion	Placenta Amnion
6	chr6:29717000-29717800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr6:29717000-29717800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
8	chr6:29717000-29718000	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
9	chr6:29717000-29720000	Enhancers	Spleen	Spleen
10	chr6:29717200-29717800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr6:29717200-29717800	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
12	chr6:29717200-29717800	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
13	chr6:29717200-29717800	Bivalent Enhancer	Fetal Intestine Large	intestine
14	chr6:29717200-29717800	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 29	rectum
15	chr6:29717200-29717800	Flanking Active TSS	GM12878-XiMat	blood
16	chr6:29717200-29718200	Enhancers	Esophagus	oesophagus
17	chr6:29717200-29719600	Weak transcription	HSMM	muscle
18	chr6:29717400-29717800	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr6:29717400-29717800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
20	chr6:29717400-29717800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
21	chr6:29717400-29717800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
22	chr6:29717400-29717800	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
23	chr6:29717400-29717800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
24	chr6:29717400-29717800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr6:29717400-29717800	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
26	chr6:29717400-29717800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
27	chr6:29717400-29717800	Enhancers	Fetal Heart	heart
28	chr6:29717400-29717800	Enhancers	Pancreas	Pancrea
29	chr6:29717400-29717800	Enhancers	K562	blood
30	chr6:29717400-29718000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr6:29717400-29718000	Enhancers	Primary T helper cells PMA-I stimulated	--
32	chr6:29717400-29718000	Enhancers	Aorta	Aorta
33	chr6:29717400-29718000	Bivalent Enhancer	Fetal Muscle Leg	muscle
34	chr6:29717400-29718000	Enhancers	Ovary	ovary
35	chr6:29717400-29718200	Enhancers	Liver	Liver
36	chr6:29717400-29719400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr6:29717400-29719400	Weak transcription	Lung	lung
38	chr6:29717400-29719600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr6:29717400-29719600	Weak transcription	A549	lung
40	chr6:29717400-29719600	Weak transcription	HUVEC	blood vessel
41	chr6:29717400-29719800	Weak transcription	Muscle Satellite Cultured Cells	--
42	chr6:29717400-29719800	Enhancers	Left Ventricle	heart
43	chr6:29717400-29719800	Weak transcription	HSMMtube	muscle
44	chr6:29717400-29719800	Weak transcription	Osteobl	bone
45	chr6:29717400-29720000	Weak transcription	Pancreatic Islets	Pancreatic Islet
46	chr6:29717400-29720000	Weak transcription	Sigmoid Colon	Sigmoid Colon
47	chr6:29717600-29717800	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
48	chr6:29717600-29717800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
49	chr6:29717600-29717800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
50	chr6:29717600-29717800	Enhancers	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links